Multicenter retrospective study of chemotherapy for vulnerable patients with metastatic colorectal cancer

Multicenter retrospective study of chemotherapy for vulnerable patients with metastatic colorectal cancer - Retrospective study of vulnerable patients with metastatic colorectal cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045844

Enrollment

200

Registered

2021-10-24

Start date

2021-09-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Histologically or cytologically diagnosed adenocarcinoma of the colon or rectum (excluding the appendix and anal canal) 2) Clinically unresectable 3) Underwent palliative chemotherapy between June 2015 and December 2018 4) Age of 20 or older 5) ECOG PS of 0-2 6) Inappropriate for intensive systemic therapy

Exclusion criteria

Exclusion criteria: Inappropriate for trial judged by medical doctors or principal investigator

Design outcomes

Primary

Measure	Time frame
Progression-free survival in second-line chemotherapy	—

Secondary

Measure	Time frame
Response rate, disease control rate, progression-free survival, time to treatment failure, and overall survival in first-line chemotherapy Response rate, disease control rate, time to treatment failure, and overall survival in second-line chemotherapy Overall survival in third-line chemotherapy Reason for vulnerability	—

Countries

Japan

Contacts

Public ContactSeiichiro Mitani

Kindai University faculty of medicine Department of Medical Oncology

seiichiro.mitani@med.kindai.ac.jp072-366-0221

Outcome results